ACCREDITATION INFORMATION: Radiation Research Society's 2016 Annual Meeting
As the population of Americans and the world increases so too does the risk of developing cancer. Radiotherapy plays a prominent role in the control and eradication of nearly every type of cancer and critical to the continued and future success of radiotherapy is a fundamental understanding of radiation effects at the biophysical, radiochemical, molecular and tissue specific levels. The increasing world population also places a heavy demand on technology at many levels, many of which depend on radiation for energy production, food sterilization and medical diagnostics. Occupational and environmental exposures can contribute to secondary radiogenic cancers highlighting further the need to understand the detailed effects of ionizing radiation exposure on biological systems. The efficient and timely detection and treatment of cancer and other diseases that depend on radiation will not only improve patient outcomes and quality of life for cancer survivors, but also help resolve rising health-care expenses.
Given the critical role of radiation in the medical and select occupational settings, it is essential to provide a educational backdrop that highlights recent advances in radiation sciences that have a significant impact on health care in the US and worldwide. This conference will examine current advances in interdisciplinary approaches towards detection, prevention and treatment of primary and secondary malignancies, with an emphasis on basic science, preclinical and clinical research.
Doctors and other health professionals will be instructed on how to incorporate this new information into their own practices and make intelligent decisions regarding the treatment of cancer and survivorship issues for the optimization of health. Topical reviews will provide updates in critical areas of interest to physicians and research professionals, while research symposium and workshops will provide ample opportunity to learn about state-of-the-art breakthroughs in basic science and translational research geared toward improved patient outcomes.
Specific areas of emphasis will include:
• The use of radiation in the treatment of organ specific cancers.
• Managing adverse neurocognitive outcomes following cancer treatments.
• Treating hypoxia, inflammation and radioresistance through advancements in imaging, targeted approaches, immune and metabolic modulation.
• Origins and risks of radiogenic cancers.
• Cancer and normal tissue stem cells in disease progression and recovery from radiation injury.
This activity is designed to educate a wide range of physicians and other health care professionals including Nurse Practitioners, Registered Nurses, Pharmacists, Physicians Assistants, Clinical and Basic Science Researchers seeking to update and stay current with the rapid advancements in radiation sciences.
At the end of this activity, the participants will be able to:
- Keep abreast of current advancements in preclinical and clinical radiation research to improve cancer therapies and patient outcomes.
- Stay current with a range of technological advancements in imaging and radiation beam delivery.Refresher courses designed to update physicians and scientists at all levels on basic and clinical radiation sciences.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Amedco and The Radiation Research Society (RRS). Amedco is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation Statement
Amedco designates this live activity for a maximum of 18 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
In accordance with ACCME guidelines, RRS requires all faculty speakers to disclose all commercial relationships relative to the content of this CME activity. Individual faculty disclosure will be provided in the course syllabus for the General Session. All presentations will be peer reviewed for fair balance and evidence based medicine.
In accordance with the Americans with Disabilities Act, RRS will make every effort to accommodate special needs at this event. Please notify RRS at least 2 weeks prior to the conference to discuss accommodations at the Hilton Waikoloa Village. International callers please call 1-877-216-1919.
No commercial support was received for this educational activity.